Martin Adelson, Ph.D.
Dr. Adelson is a member of the JBS Board of Directors. He is the Chief Operating Officer for Genesis Biotechnology Group. He has extensive expertise in the development and commercialization of quality diagnostic tests through the CAP accredited, CLIA laboratory In Medical Diagnostic Laboratories in Hamilton, New Jersey. His team has developed over 130 PCR-based diagnostic assays for the detection and management of infectious diseases and cancer screening and offers these services to thousands of physicians across the United States, as well as internationally. He provides guidance on preparation of the JBS HCC test as an LDT, for the CLIA certification of the JBS lab and application for CPT codes and health insurance reimbursement negotiations.